Bebit Baby, Chippy Lee Antony, Shivil Wilson, Theertha Xavier, T. Tamilselvan


Objectives: Evaluation of the impact of pharmaceutical care on improving knowledge and medication adherence in Chronic Kidney Disease (CKD) patients.

Methods: Patient data were recorded on a data collection form after informed consent. Their knowledge and medication adherence were evaluated by questionnaire and it was quantified. Patients were counselled using patient information leaflets. Re-assessment was made during follow-up.

Results: Medication adherence among patients was classified as low, medium and high adherence. Knowledge was classified under three categories excellent, average and poor. There was a considerable improvement in knowledge and medication adherence irrespective of age and gender. The study was statistically significant with P<0.05.

Conclusion: The efforts to increase awareness on CKD patients such as providing patient counselling and continuous education could enhance adherence to therapies and thus could improve clinical outcomes and quality of life.


Knowledge, Medication Adherence, Chronic Kidney Disease (CKD)

Full Text:




Agarwal SK, Srivastava RK. Chronic kidney disease in India: challenges and solutions. Karger Nephron Clin Practice 2009;3:111-97.

Hala I, Abo Deif, Mohga Selim. Effect of an educational programme on adherence to therapeutic regimen among CKD stages five patients under maintenance hemodialysis. J Education Practice 2015;6:21-33.

Stephanie Belaiche, Thierry Romanet, Robert Bell, Jean Calop, Benoit Allenet, Philippe Zaoui. Pharmaceutical care in chronic kidney disease: experience at Grenoble University Hospital from 2006 to 2010. J Nephrol 2012;25:558-65.

EJC Magacho, LC Ribeiro, A Chaoubah, MG Bastos. Adherence to drug therapy in kidney disease. Brazilian J Med Biol Res 2011;44:258-62.

Dena E Rifkin, M Barton Laws, Madhurmathi Rao, VS Balakrishnan, Mark J Sarnak, Ira B Wilson. Medication adherence behaviour and priorities among older adults with CKD: A semi-structured interview study. Am J Kidney Dis 2010;56:439-46.

Moreira LB, Fernandes PF, Mota RS, Monte FS, Galvao RI, Sousa DF, et al. Medication noncompliance in chronic kidney disease. Jnephrol 2008;21:34-62.

Wei Leng Chow, Veena D Joshi, Aung Soe Tin, Saskia Van der Erf. Limited knowledge of chronic kidney disease primary care patients a cross-sectional survey. BMC Nephrol 2012;13:471-99.

Gunar Stemer, Rosa Lemmens-Gruber. Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review. BMC Nephrol 2011;12:35-42.

Vanitha Rani. The impact of continuous patient counselling on knowledge, attitude, and practices and medication adherence of diabetic patients attending outpatient pharmacy services. Asian J Pharm Clin Res 2016;9:364-9.

Vanitha Rani. The impact of clinical pharmacist provided education on medication knowledge and adherence of hemodialysis patients in a south Indian university hospital. Asian J Pharm Clin Res 2013;6:24-7.

Rouzaud-Laborde Charlotte, Damery Lea1. Aspirin, patient knowledge and pharmaceutical information after a stroke. Int J Curr Pharm Clin Res 2015;5:119-23.

DOI: http://dx.doi.org/10.22159/ijpps.2017v9i1.15053


  • There are currently no refbacks.